Network origin in Ben Sattelle first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ben Sattelle via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Founder Founder | |
| University of Oxford | College/University | Doctorate Degree | |
| The University of Edinburgh | College/University | Undergraduate Degree | |
| The University of Manchester | College/University | Doctorate Degree | |
Imperagen Ltd.
 Imperagen Ltd. Miscellaneous Commercial ServicesCommercial Services Imperagen Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development. The company is based in Manchester, UK. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| United Kingdom | 6 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Commercial Services | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 4 |
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| President | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Andrew Almond | 5 |
| Charles Douglas Blundell | 3 |
- Stock Market
- Insiders
- Ben Sattelle
- Company connections
